ライフサイエンスコーパス: AVNRT

1 AVNRT is an uncommon AF trigger seen more frequently in

2 Six of 22 AVNRT recurrences (27%) occurred >/=5 years after ablati

3 about the long-term results >/=3 years after AVNRT ablation in pediatric patients.

4 sought to characterize patients with AF and AVNRT and assess clinical outcomes after ablation.

5 nt from that required for atrial flutter and AVNRT.

6 Cs during tachycardia can distinguish JT and AVNRT with 100% specificity in adult patients.

7 al activation between ventricular pacing and AVNRT in only 21 of 46 patients.

8 Atypical AVNRT with eccentric retrograde left-sided activation wa

9 ricular node reentry (AVNRT; n=82), atypical AVNRT (n=13), permanent junctional reciprocating tachyca

10 uction intervals during typical and atypical AVNRT that occurred in the same patient.

11 tients with AVNRT, both typical and atypical AVNRT were induced at electrophysiology study by pacing

12 nd 65% of patients with typical and atypical AVNRT, respectively.

13 s usually possible to differentiate atypical AVNRT from ORT using a septal accessory pathway, a defin

14 Thirteen patients (65%) displayed atypical AVNRT with fast-slow characteristics.

15 PI-TCL are useful in distinguishing atypical AVNRT from ORT using a septal accessory pathway.

16 n age 48.5+/-18.1 years, 68 female, atypical AVNRT or coexistent atypical and typical AVNRT without o

17 n, as applied for typical cases, in atypical AVNRT.

18 with typical AVNRT (0%) P<0.001, or atypical AVNRT (0%) but similar to those with AT (11%) and PJRT (

19 In 30 patients with atypical AVNRT and 44 patients with ORT using a septal accessory

20 All 30 patients with atypical AVNRT and none of the 44 patients with ORT using a septa

21 r variables predicted ablation success (AVJ, AVNRT, or left free wall AP ablation and an experienced

22 To determine the prevalence of concomitant AVNRT and AF, 629 consecutive patients referred for cath

23 During AVNRT, only 2 patients had a single early site with foca

24 Retrograde atrial activation during AVNRT (337 +/- 43 ms) and ventricular pacing at a simila

25 ventricular pacing and in 43 patients during AVNRT.

26 ventricular pacing and in 26 patients during AVNRT.

27 hazard ratio of at least 3.6 for exhibiting AVNRT compared with the general population.

28 Familial AVNRT prevalence is higher than previously believed sugg

29 This indicates a familial AVNRT prevalence of 127 cases per 10 000 (95% confidence

30 e prevalence and characteristics of familial AVNRT among patients who underwent radiofrequency ablati

31 nts at ablation were younger in the familial AVNRT group when compared with the sporadic AVNRT group

32 lation reports of all patients with familial AVNRT (at least 2 first-degree family members) who under

33 After inclusion of 4 families with familial AVNRT who underwent ablation at another hospital our pop

34 ade fast pathway conduction during slow-fast AVNRT and anterograde fast pathway conduction during fas

35 ing slow-pathway radiofrequency ablation for AVNRT were assigned to autonomic blockade (0.2 mg/kg pro

36 Cryo-therapy may be more effective for AVNRT than septal AVRT.

37 The success rate for AVNRT was higher than for AVRT (95.5% vs. 62.5%, p < 0.0

38 pothesized that JT can be distinguished from AVNRT based on specific responses to premature atrial co

39 tial AVNRT ablation, calculated freedom from AVNRT was 96% at 1 year, 94% at 3 years, 93% at 5 years,

40 f AVNRT ablation did not impact freedom from AVNRT.

41 Twenty-two had AVNRT, 8 AVRT, and 1 VT.

42 ation of any non-PV trigger of AF, including AVNRT.

43 ndeterminate rhythm, the technique indicated AVNRT in 1 patient and JT in 7 patients, and the test wa

44 re were 27 patients (4.3%) who had inducible AVNRT at the time of AF ablation.

45 t initiated AF and the presence of inducible AVNRT.

46 After the initial AVNRT ablation, calculated freedom from AVNRT was 96% at

47 re divided into 3 groups: clinically obvious AVNRT, clinically obvious JT, and clinically indetermina

48 In the 26 cases of clinically obvious AVNRT, the sensitivity and specificity of the test were

49 Cumulatively, catheter ablation of AVNRT continued to be effective in >90% of our pediatric

50 Ablation of AVNRT in patients with AF was associated with improved o

51 n for patients who had undergone ablation of AVNRT.

52 tion is involved and confirms a diagnosis of AVNRT.

53 Successful elimination of AVNRT was achieved in all patients.

54 The slow-fast form of AVNRT was also inducible in 17 of the 20 patients.

55 ither the fast-slow or the slow-slow form of AVNRT.

56 tion energy, and the procedural end point of AVNRT ablation did not impact freedom from AVNRT.

57 Procedural end point of AVNRT ablation had been either SP ablation (no residual

58 thway conduction times during the 2 types of AVNRT were calculated.

59 Although there are abundant data on AVNRT ablation in adult patients, little is known about

60 with 44 tachycardias suggesting either JT or AVNRT based on a short ventriculo-atrial interval and ap

61 =59), typical atrioventricular node reentry (AVNRT; n=82), atypical AVNRT (n=13), permanent junctiona

62 ion intervals during slow-fast and fast-slow AVNRT in the same patient, fast pathway conduction times

63 hat typical slow-fast and atypical fast-slow AVNRT use different anatomic pathways for fast conductio

64 ade fast pathway conduction during fast-slow AVNRT was 41.8+/-39.7 ms and was significantly different

65 AVNRT group when compared with the sporadic AVNRT group (44.2+/-19 versus 54.8+/-18 years old, P=0.0

66 ged </=18 years who had undergone successful AVNRT ablation were analyzed.

67 way is the therapy of choice for symptomatic AVNRT, regardless of whether the typical or atypical for

68 rioventricular nodal re-entrant tachycardia (AVNRT) do not use the same limb for fast conduction, but

69 trioventricular node re-entrant tachycardia (AVNRT) from orthodromic reciprocating tachycardia (ORT)

70 atrioventricular nodal re-entry tachycardia (AVNRT), atrioventricular reciprocating tachycardia (AVRT

71 atrioventricular node re-entry tachycardia (AVNRT).

72 oventricular node reciprocating tachycardia (AVNRT) can be associated with eccentric retrograde left-

73 trioventricular nodal reentrant tachycardia (AVNRT) are scarce, and the optimal ablation method has n

74 trioventricular nodal reentrant tachycardia (AVNRT) can also cause or coexist with AF.

75 trioventricular nodal reentrant tachycardia (AVNRT) is considered a sporadic disease occurring in app

76 ical form of AV nodal reentrant tachycardia (AVNRT) underwent selective radiofrequency ablation of th

77 trioventricular nodal reentrant tachycardia (AVNRT) who underwent fluoroscopically guided procedures

78 substrate for AV node reentrant tachycardia (AVNRT), ablation of the slow pathway potentially may be

79 trioventricular nodal reentrant tachycardia (AVNRT), an accessory pathway (AP), or the atrioventricul

80 trioventricular nodal reentrant tachycardia (AVNRT).

81 atients with AV nodal reentrant tachycardia (AVNRT).

82 t AP who had AV nodal reentrant tachycardia (AVNRT).

83 ing in cure of AV nodal reentry tachycardia (AVNRT) has led to the concept that these pathways are di

84 cal AVNRT or coexistent atypical and typical AVNRT without other concomitant arrhythmia was diagnosed

85 logy study and catheter ablation for typical AVNRT.

86 those with AVRT (15%) compared with typical AVNRT (0%) P<0.001, or atypical AVNRT (0%) but similar t

87 l (VA) intervals (13%) compared with typical AVNRT (0%), P<0.005.

88 nd sex-matched control patients with typical AVNRT.

89 Of these, 13 underwent AVNRT ablation without PV isolation.

90 mination at the AV node in AVRT (85%) versus AVNRT (86%) after adenosine, but patients with AVRT show

91 However, it is not known whether AVNRT can occur with eccentric retrograde left-sided act

92 d with the rest of the cohort, patients with AVNRT and AF were younger at the time of symptom onset (

93 was demonstrated in 6% of all patients with AVNRT masquerading as tachycardia using a left-sided acc

94 First-degree relatives of patients with AVNRT presented a hazard ratio of at least 3.6 for exhib

95 We studied 2079 patients with AVNRT subjected to slow pathway ablation.

96 p 21.4+/-9.4 months); however, patients with AVNRT targeted for ablation were more likely to be AF fr

97 We studied 356 patients with AVNRT who underwent catheter ablation.

98 In 20 of 1299 patients with AVNRT, both typical and atypical AVNRT were induced at e

99 cluded AP conduction in all 53 patients with AVNRT.

100 ed a total of 24 families (50 patients) with AVNRT.

101 whom 20 had >/=1 first-degree relatives with AVNRT.